TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: learning effect of SKT-M immediate recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Arterial oxygen (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory rate (RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: pH improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shortened hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Geometric mean titers for HI antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion and seroprotection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antigen-specific CD4 T cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average corneal refractive change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End diastolic interventricular septum thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: eradication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Primary patency rates at 15, 30, and 45 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Initial clinical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Median duration of additional function/patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Clinical Global Impression-based clinical responders (MCID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menopause Quality of Life-based clinical responders (MCID)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: decrease in disc-osteophyte complex size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in ulcer size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in visual analog scale scores of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in scores of erythema and exudation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication non-adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reproducibility of tooth colour measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of sinus rhythm (SR) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cost per quality-adjusted life-year (QALY) gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neuropathy events
Endpoint domain: Adverse events/effects
Primary endpoint: Motor neuropathy incidence
Endpoint domain: Adverse events/effects
Primary endpoint: combined non-CABG TIMI major or minor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Rotational stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: incidence of acute rejection episode
Endpoint domain: Adverse events/effects
Primary endpoint: IIEF-EF domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sexual functioning
Primary endpoint: duration of erection leading to successful intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sexual functioning
Primary endpoint: Median nerve conduction latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensory nerve action potential amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum concentrations of NGMN and EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum alkaline phosphatase concentration normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Urinary Bladder Cancer (UBC) risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Second Cancers (SC) risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: movement duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smoothness (normalized jerk index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm childbirth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Arousal dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Time intervals from dosing to entry into active labor and delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse Pressure (PP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Arterial Compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aortic Arch Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Discussion of preferences for cardiopulmonary resuscitation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Combined mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: voluntary alcohol intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor skills assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ETDRS letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in central macular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients discharged with self-catheterism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery of bladder function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal and CRA blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with undetectable CMV DNAemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of patients with CMV DNAemia below 5000 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Adherence to stent removal/exchange
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dilation of MMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Contraction of MMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Treatment-related grade 3/4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Preference for taste of cefdinir
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for smell of cefdinir
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bone mineral density of the spine and hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of renal artery stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Absolute median survival
Endpoint domain: Mortality/survival
Primary endpoint: Objective responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectal temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carbon dioxide end‐tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Six-minute walk distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual hospitalization days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: acute otitis media episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Serum ferritin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean number of URTI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic equivalents (METs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective rating of difficulty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 14-day mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hb response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Hb changes from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total symptom score for rhinitis and conjunctivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin reactivity to grass and rye pollen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tobacco quit rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pseudarthrosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Graft collapse rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in left ventricular end-systolic volume (LVESV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of renal failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of renal replacement therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Severity of lower limb edema (LLE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bronchoscopist-reported airway secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of MR angiography for identifying lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Positive predictive value of MR angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage of patients avoiding catheter arteriography
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of DNR orders written by houseofficers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of charts documenting attention to any concurrent care concerns (CCCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of CCCs addressed per DNR order
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Outcome Scale score at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Coma Scale score at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drowsiness and disorientation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental acceptance of sedation route
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptance of oral route compared to inhalation route
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Any respiratory tract infection
Endpoint domain: Adverse events/effects
Primary endpoint: Lower respiratory tract infections
Endpoint domain: Adverse events/effects
Primary endpoint: Pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: ADMA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Distance visual acuity >/= 0.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected near acuity >/= 0.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of wearing spectacles
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Positive attitude towards conducting research
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Barriers encountered by physicians during research
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient cooperation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: global health status/QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of severe bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of mild and minor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of MACE
Endpoint domain: Mortality/survival
Primary endpoint: CAP phase A3 frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMMA/SB index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physician global
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HAQ
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF‐36 physical component score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Airway management failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Corrected Distance Visual Acuity (CDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refractive prediction errors within ±0.50 diopter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of free amino acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentrations of bile acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modulation of indole derivative compounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk of new claims for depression
Endpoint domain: Adverse events/effects
Primary endpoint: Need for procedures for BPH-related events
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area of tissue harvested
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 2 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: wrist spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wrist ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypotension and related symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Hamilton Rating Scale for Depression (HAM-D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSP (Temporal Summation of Pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ApEn after endotoxin exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resolution of symptoms of cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Antibiotic prescribing rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Supplemental narcotic requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in HbA1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in CES-D
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HBsAg seroprevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of PLC
Endpoint domain: Mortality/survival
Primary endpoint: Mortality rates of severe end-stage liver diseases
Endpoint domain: Mortality/survival
Primary endpoint: Automatic activation of negative alcohol associations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: visual analog scale pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospitalization costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: exercise-induced oxidative stress response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of genital irritation
Endpoint domain: Adverse events/effects
Primary endpoint: Willingness to use the product for HIV prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in alcohol drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of children reporting back pain at least once a month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in back care knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Severity of postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ability to identify MSK US anatomy accurately
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CS-PFP10 total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kansas City Cardiomyopathy Questionnaire overall summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Esophageal transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Participation rate in group discussions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Response rates regarding outcome data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fulfillment of purpose in participating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FFF (Freedom from Failure) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: canal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume of dentine removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: working time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemoglobin level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Decrement of PaCO2 from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Need for intubation
Endpoint domain: Adverse events/effects
Primary endpoint: quality of breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total release of fluoride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LF variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalized LF variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recent reproductive coercion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of children with rSBA-MenC titers ≥1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-PRP antibody concentrations ≥0.15 μg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: average final assessment score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction in eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative incidence of rejection or treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Length of survival
Endpoint domain: Mortality/survival
Primary endpoint: Back functional disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global outcome satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: color stability of resin composites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or disability at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Griffiths General Quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraluminal water flow rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes